Bacterial therapy tolerable, shows early promise in patients with advanced solid tumors
Sunday, September 30, 2018 - 17:10
in Health & Medicine
A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to new data.